The Epstein-Barr virus (EBV) early promoter DR contains a cis-acting element responsive to the EBV transactivator EB1 and an enhancer with constitutive and inducible activities.

Por Chavrier, P, Gruffat, H, Chevallier-Greco, A, Buisson, M, Sergeant, A
Publicado em 1989

The Epstein-Barr virus (EBV) DR enhancer contains two functionally different domains: domain A is constitutive and cell specific, domain B is transactivated by the EBV early protei...

Por Chevallier-Greco, A, Gruffat, H, Manet, E, Calender, A, Sergeant, A
Publicado em 1989

Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter.

Por Chevallier-Greco, A, Manet, E, Chavrier, P, Mosnier, C, Daillie, J, Sergeant, A
Publicado em 1986